- Finch Therapeutics press release (NASDAQ:FNCH): Q1 GAAP EPS of -$0.52.
- Revenue of $0.35M.
- Susan Graf appointed board chair and Howard Franklin chief medical officer.
- Shares +3.59%.
Finch Therapeutics GAAP EPS of -$0.52, revenue of $0.35M
Recommended For You
More Trending News
About FNCH Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
FNCH | - | - |
Finch Therapeutics Group, Inc. |